enGene Therapeutics Inc. (ENGN): SC 13G/A filed Feb 14, 2024

Form type

SC 13G/A

Filing date

Feb 14, 2024

Accession number

0001193125-24-035047

Filer

enGene Therapeutics Inc. (CIK 1980845)